Metraipolis › archive › dc_c4dc092485de
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models — Europe PMC PMID:42090721
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42090721
- DOI
- 10.1158/2767-9764.crc-25-0493
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T23:24:44.141Z
- SHA-256 of the archived text
e2e40c25f4cbca87d70d27ffdaac65cddf10645722a6cd4d098aa3c45027a07b- Stable URL of this page
https://metraipolis.com/documento/dc_c4dc092485de
How to cite
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models — Europe PMC PMID:42090721 — Europe PMC (en), https://europepmc.org/article/MED/42090721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4dc092485de (Metraipolis archive dc_c4dc092485de, sha256 e2e40c25f4cbca87d70d27ffdaac65cddf10645722a6cd4d098aa3c45027a07b)
BibTeX
@misc{dcc4dc092485de,
title = {MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models — Europe PMC PMID:42090721},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42090721},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4dc092485de; sha256 e2e40c25f4cbca87d70d27ffdaac65cddf10645722a6cd4d098aa3c45027a07b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42090721. Agents can read the archived copy with the MCP tool read_document.